246 related articles for article (PubMed ID: 7083201)
1. Significance of aromatase activity in human breast cancer.
Miller WR; Hawkins RA; Forrest AP
Cancer Res; 1982 Aug; 42(8 Suppl):3365s-3368s. PubMed ID: 7083201
[TBL] [Abstract][Full Text] [Related]
2. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
Dao TL
Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
[TBL] [Abstract][Full Text] [Related]
3. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Santen RJ
Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
[TBL] [Abstract][Full Text] [Related]
4. Aromatase in the normal breast and breast cancer.
Brodie A; Lu Q; Nakamura J
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):281-6. PubMed ID: 9365202
[TBL] [Abstract][Full Text] [Related]
5. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
Abul-Hajj YJ
Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
[TBL] [Abstract][Full Text] [Related]
8. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
MacIndoe JH; Woods GR; Etre LA; Covey DF
Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
11. A reassessment of the role of breast tumor aromatization.
Bradlow HL
Cancer Res; 1982 Aug; 42(8 Suppl):3382s-3386s. PubMed ID: 7083204
[TBL] [Abstract][Full Text] [Related]
12. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
13. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
Morris KT; Toth-Fejel S; Schmidt J; Fletcher WS; Pommier RF
Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
[TBL] [Abstract][Full Text] [Related]
14. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers.
Lu Q; Nakmura J; Savinov A; Yue W; Weisz J; Dabbs DJ; Wolz G; Brodie A
Endocrinology; 1996 Jul; 137(7):3061-8. PubMed ID: 8770932
[TBL] [Abstract][Full Text] [Related]
15. Biological significance of aromatase activity in human breast tumors.
Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
17. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
18. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.
Singer CF; Fink-Retter A; Gschwantler-Kaulich D; Thalhammer T; Hudelist G; Mueller R; Czerwenka K; Kubista E
Endocr Relat Cancer; 2006 Dec; 13(4):1101-7. PubMed ID: 17158756
[TBL] [Abstract][Full Text] [Related]
19. Estradiol induction of retinoic acid receptors in human breast cancer cells.
Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
